Meyahealth
HomeGeneticsGeneSGCB gene
Back to Gene
SGCB gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

SGCB gene

The SGCB gene provides instructions for the beta-sarcoglycan protein, which plays a vital role in the structural stability of muscle tissue.

Normal Function

The SGCB gene provides instructions for making the beta component (subunit) of the sarcoglycan protein complex. This complex is located in the membrane surrounding muscle cells and helps maintain the structure of muscle tissue by stabilizing the dystrophin complex.

The dystrophin complex, which includes dystrophins and dystroglycans, acts as an anchor that connects the muscle cell's internal structural framework (cytoskeleton) to the lattice of proteins outside the cell (extracellular matrix). This connection strengthens muscle fibers and protects them from injury during muscle contraction and relaxation.

Health Conditions Related to Genetic Changes

Limb-girdle muscular dystrophy

Mutations in the SGCB gene are associated with limb-girdle muscular dystrophy.

Genomic Location

The SGCB gene is found on chromosome 4.

Frequently Asked Questions

Management focuses on multidisciplinary care. A tailored physiotherapy program emphasizes strength training, stretching, and gait training to preserve ambulation. Occupational therapy can assist with daily‑living adaptations. Some clinicians use corticosteroids or exon‑skipping agents in clinical trials, but these are not standard of care. Cardiac evaluation is advised because a minority of patients develop cardiomyopathy; early ACE‑inhibitor therapy may be beneficial if heart dysfunction is identified.
Carriers (heterozygotes) are usually asymptomatic because SGCB disease is recessive. However, rare reports describe mild cardiac or muscle findings in some carriers. It is reasonable for carriers to have a baseline physical exam and, if there is a family history of cardiomyopathy, an ECG and echocardiogram, but routine long‑term screening is not required.
The first clues often appear in the teenage years and include difficulty climbing stairs, rising from a seated position, or running long distances. Subtle calf muscle enlargement (pseudohypertrophy) and a waddling gait may be noticed before obvious weakness. Some patients also report frequent falls or trouble lifting objects overhead.
Testing is done by sequencing the SGCB gene (next‑generation sequencing panel or whole‑exome sequencing) to detect point mutations, small insertions/deletions, and copy‑number changes. A peripheral blood draw (5‑10 mL) is the standard specimen. In rare cases, skin fibroblasts or muscle tissue may be used if blood DNA is insufficient.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ